Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat

Acta Physiol Scand. 1999 Jan;165(1):15-23. doi: 10.1046/j.1365-201x.1999.00456.x.

Abstract

It was examined to what extent congestive heart failure (CHF) in rats, induced by ligation of the left coronary artery, affects the vascular responses to the vasodilatory substances acetylcholine (ACh), calcitonin gene-related peptide (CGRP), and substance P (SP). After induction of CHF status, the basilar, mesenteric and renal arteries and the iliac vein were studied in vitro. Dilatory responses were determined in relation to pre-contraction by the thromboxane mimetic U46619. Sham-operated animals (Sham) served as controls. U46619 induced stronger contraction in CHF basilar and renal arteries compared with the corresponding segments in Sham. ACh induced concentration-dependent dilations in all vessels examined with no difference of maximum relaxation or potency between CHF and Sham. SP induced weak dilations in all arteries examined while the response was markedly attenuated in CHF iliac veins compared with Sham (Emax% 12.2 +/- 3.4 vs. 32.3 +/- 4.8, P = 0.01). The CGRP induced dilation in the CHF basilar artery was weaker (Emax% 18.6 +/- 6.5 vs. 66.9 +/- 5.0, P < 0.001) and less potent (pEC50: 8.2 +/- 0.2 vs. 9.0 +/- 0.2, P = 0.01) compared with Sham. Further, CGRP was less potent in the renal artery of CHF rats compared with Sham (pEC50: 8.1 +/- 0.2 vs. 9.5 +/- 0.3, P < 0.01). In the CHF iliac vein, CGRP was more potent compared with Sham (pEC50: 9.7 +/- 0.4 vs. 8.3 +/- 0.4, P < 0.05). It can be concluded CHF is accompanied by alterations in the vascular response to the dilatory substances studied. The changes differ between vascular beds and between the different substances.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Acetylcholine / pharmacology*
  • Animals
  • Calcitonin Gene-Related Peptide / pharmacology*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Heart Failure / drug therapy
  • Heart Failure / physiopathology*
  • In Vitro Techniques
  • Male
  • Myocardial Infarction / pathology
  • Myocardial Infarction / physiopathology
  • Myocardial Ischemia / drug therapy
  • Myocardial Ischemia / pathology
  • Myocardial Ischemia / physiopathology
  • Potassium / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Substance P / pharmacology*
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*
  • Vasodilation / physiology
  • Vasodilator Agents / pharmacology

Substances

  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Substance P
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Calcitonin Gene-Related Peptide
  • Acetylcholine
  • Potassium